Loading...
Adjuvant and Neoadjuvant Systemic Therapy for Pancreas Adenocarcinoma
The last two decades of research in the adjuvant setting of pancreas adenocarcinoma have established the value of adjuvant systemic therapy as being able to delay recurrence and increase overall survival. International standards of care in the adjuvant setting include either 6 months of gemcitabine...
Na minha lista:
| Udgivet i: | Semin Oncol |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4991774/ https://ncbi.nlm.nih.gov/pubmed/25726058 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.seminoncol.2014.12.012 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|